Mycophenolate mofetil reduces graft loss due to chronic allograft nephropaty.
Falkiewicz
K
K
Department of Nephrology, Medical University of Wrocław, 57 Traugutta Str, 50-417 Wrocław, Poland.
Kuriata
M
M
Boratyńska
M
M
Klinger
M
M
Szepietowski
T
T
Patrzałek
D
D
Szyber
P
P
D000328:Adult; D001794:Blood Pressure; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D014184:Transplantation, Homologous / Q000276:immunology / Q000473:pathology; D017211:Treatment Failure; D014280:Triglycerides / Q000097:blood
D007166:Immunosuppressive Agents; D014280:Triglycerides; D002784:Cholesterol; D003404:Creatinine; D009173:Mycophenolic Acid; D008775:Methylprednisolone